Location of Repository

Association of the CCR5 gene with juvenile idiopathic arthritis

By A. Hinks, P. Martin, E. Flynn, S. Eyre, J. Packham, A. Barton, J. Worthington, W. Thomson, J. [CAPS and BSPAR Study Groups] Gardner-Medwin, Childhood Arthritis Prospective Study (CAPS), UKRAG Consortium and BSPAR Study Group

Abstract

The CC chemokine receptor 5 (CCR5) has been shown to be important in the recruitment of T-helper cells to the synovium, where they accumulate, drive the inflammatory process and the consequent synovitis and joint destruction. A 32 base-pair insertion/deletion variant (CCR5Δ32) within the gene leads to a frame shift and a nonfunctional receptor. CCR5Δ32 has been investigated for its association with juvenile idiopathic arthritis (JIA), with conflicting results. The aim of this study was to investigate whether CCR5Δ32 is associated with JIA in an UK population. CCR5Δ32 was genotyped in JIA cases (n=1054) and healthy controls (n=3129) and genotype and allele frequencies were compared. A meta-analysis of our study combined with previously published studies was performed. CCR5Δ32 was significantly associated with protection from developing JIA, in this UK data set (P(trend)=0.006, odds ratio (OR) 0.79 95% confidence interval (95% CI): 0.66-0.94). The meta-analysis of all published case-control association studies confirmed the protective association with JIA (P=0.001 OR 0.82 95% CI: 0.73-0.93). CCR5Δ32 is a functional variant determining the number of receptors on the surface of T cells, and it is hypothesized that the level of CCR5 expression could influence the migration of proinflammatory T cells into the synovium and thus susceptibility to JIA

Publisher: Macmillan Publishers Limited
Year: 2010
OAI identifier: oai:eprints.gla.ac.uk:48914
Provided by: Enlighten

Suggested articles

Preview

Citations

  1. (2005). A et al. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann Rheum Dis
  2. (2008). Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study. Rheumatology (Oxford) doi
  3. (1999). Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum doi
  4. (2010). Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis. Genes Immun doi
  5. (2009). Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritis. Arthritis Rheum doi
  6. (2009). Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum doi
  7. (2006). Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis. Genes Immun doi
  8. (2003). Biological relevance of the polymorphism in the CCR5 gene in refractory and nonrefractory rheumatoid arthritis in Mexicans. Clin Exp Rheumatol
  9. (1998). CC chemokine receptor 5 polymorphism in rheumatoid arthritis.
  10. (2000). CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun doi
  11. (2009). CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation. doi
  12. (2007). Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes. Clin Immunol doi
  13. Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases. doi
  14. (2003). e r e d i aA ,A m o r o s oA ,D a v i sC ,L eN ,R e a r d o nE ,D o m i n i q u eJ K et al. Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. Proc Natl Acad Sci USA
  15. (1995). Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science doi
  16. (2000). Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivo. doi
  17. (2001). International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis: second revision,
  18. (2007). Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis. doi
  19. (2002). Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology doi
  20. (2006). Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis. Genes Immun doi
  21. (2009). Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis. Arthritis Res Ther doi
  22. (2009). Overlap of disease susceptibility loci for rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). Ann Rheum Dis (e-pub ahead of print 11 doi
  23. (1997). Pathogenesis of juvenile chronic arthritis: genetic and environmental factors. Arch Dis Child
  24. (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses. doi
  25. (2003). Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. Proc Natl Acad Sci USA doi
  26. (2002). Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration. doi
  27. (1997). Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban,
  28. (2007). Rheumatoid arthritis association at 6q23. Nat Genet doi
  29. (1999). Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol doi
  30. (2000). Selective recruitment of polarized Tcells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum doi
  31. (2008). Shared and distinct genetic variants in type 1 diabetes and celiac disease. doi
  32. Silman A et al. Genetic variation in CCR5 does not predict clinical outcome in inflammatory arthritis. doi
  33. (2006). The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis. Rheumatology (Oxford) doi
  34. (1998). The delta32 deletion of CCR5 receptor in rheumatoid arthritis. Arthritis Rheum doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.